AGP’s generic drug manufacturing facility recently received inspection approvals by both the Food and Drug Board of Ghana (FDB) and the Ghana Standards Board (GSB).
EWPI stated that the manufacturing process is expected to go through several phases of testing to ensure that the quality and approval standards is met.
EWPI president, Brandon Keks said that he was impressed with the manufacturing facility and its team of chemist, pharmacists and operators.
"I believe we should be on schedule to be in full production by the January 2011 target date," Keks said.
EWPI confirms that initial production of medicines will commence in December with full production and availability expected to be ready in January.